Buy Day today: Good (67) Broad market participation · no major macro event

Repligen Corporation (RGEN)

Healthcare Medical Instruments & Supplies

147.10 $

+4.3% vs. previous close

Closing price · As of: 3. Aug 2026

Repligen Corporation (RGEN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 2,950 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow

Annual Quarterly

All figures in millions of USD.

Balance Sheet RGEN
Tick rows to compare them in a chart (up to 4)	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	2,514	2,831	2,849	2,862	2,831	2,830	2,852	2,902	2,924	2,950	2,931	2,950
Current Assets	978	1,111	1,133	1,159	1,132	1,066	1,032	1,057	1,096	1,137	1,161	1,201
Cash	631	751	781	809	784	757	697	709	749	566	583	607
Cash & Short-Term Investments	631	751	781	809	784	757	697	709	749	768	785	810
Receivables	106	124	116	123	129	134	147	157	149	159	152	158
Inventory	211	202	198	191	182	143	153	156	160	170	179	187
Goodwill	869	987	986	986	988	1,031	1,082	1,114	1,113	1,114	1,107	1,104
Intangible Assets	344	407	388	380	381	398	409	406	395	386	368	358
Total Liabilities	526	866	879	876	814	857	867	840	841	844	825	838
Current Liabilities	363	165	178	174	108	127	152	123	131	136	126	133
Short-Term Debt	289	75	79	82	12	15	15	16	19	22	21	19
Accounts Payable	19	20	19	21	21	32	27	26	29	30	35	33
Long-Term Debt	–	510	514	518	522	526	530	534	538	542	547	551
Shareholders' Equity	1,989	1,965	1,971	1,986	2,017	1,973	1,985	2,062	2,083	2,106	2,105	2,112
Retained Earnings	464	433	441	444	441	407	413	428	443	456	465	470
Shares Outstanding	57	56	57	56	57	56	57	57	57	57	57	57

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Cookie settings